Azithromycin Dosing for Young Infants

Dosing Guidelines

For infants under 6 months of age, including 1-month-old infants, azithromycin should be administered at 10 mg/kg once daily for 5 days, according to the Centers for Disease Control and Prevention (CDC) 1, 2
Azithromycin is administered as a single daily dose, which simplifies the dosing regimen compared to other macrolides, as recommended by the CDC 1
The medication is available as azithromycin dihydrate suspension for oral administration in young infants, as stated by the CDC 1

Azithromycin is the preferred macrolide antibiotic for infants under 1 month of age, according to the CDC 2
It has replaced erythromycin as the preferred agent due to safety concerns with erythromycin in this age group, as noted by the CDC 2
Erythromycin is not preferred in infants under 1 month due to the risk of infantile hypertrophic pyloric stenosis (IHPS), as reported by the CDC 1, 2

Monitor for potential side effects, which may include abdominal discomfort, diarrhea, nausea, vomiting, headache, and dizziness, as advised by the CDC 1, 2
Azithromycin should not be administered simultaneously with aluminum- or magnesium-containing antacids as they reduce the rate of absorption, according to the CDC 1
To date, use of azithromycin in infants under 1 month has not been associated with infantile hypertrophic pyloric stenosis (IHPS), unlike erythromycin, as stated by the CDC 2
Infants under 1 month who receive azithromycin should still be monitored for IHPS and other serious adverse events, as recommended by the CDC 2

For pertussis treatment or post-exposure prophylaxis in infants under 1 month, azithromycin is the recommended antimicrobial agent, according to the CDC 2

The benefit of treating serious infections in this age group outweighs the potential risks of antimicrobial therapy, as stated by the CDC 2
The FDA has not specifically licensed macrolides for use in infants under 6 months, but clinical evidence supports the use of azithromycin in this population, as noted by the CDC 2
Azithromycin has fewer drug interactions compared to other macrolides like erythromycin, according to the CDC 1